MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
63 hedge funds and large institutions have $33.6M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
-13
Holders Change %
-17.11%
% of All Funds
1.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
18
Reduced
20
Closed
15
Calls
$195K
Puts
$233K
Net Calls
-$38K
Net Calls Change
-$1.32M
Top Buyers
| 1 |
CC
Clearline Capital
New York
|
$1.71M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
$3.06M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
$2.96M |
| 4 |
Two Sigma Investments
New York
|
$302K |
| 5 |
JPMorgan Chase & Co
New York
|
$294K |
